The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression

Zeeshan Ramzan, Ammar B. Nassri, Sergio Huerta

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Long-standing gastroesophageal reflux disease can result in transformation of the normal squamous lining of the esophagus into columnar epithelium (with goblet cells). This condition, Barrett's esophagus (BE), is considered a risk factor for esophageal cancer (EAC) and may be the cause of the increased incidence of EAC over the last few decades. Currently, endoscopy with biopsies revealing dysplasia is the best predictor for neoplastic progression in patients with BE. However, the use of more sophisticated imaging techniques and biomarkers with or without histological assessment may be helpful in more accurate prediction of malignant transformation in these patients. New approaches to the evaluation of BE such as epigenetics, miRNA analysis, detection of DNA content abnormalities and loss of heterozygosity have great potential to shed light on the complex gastroesophageal reflux disease -BE-EAC sequence.

Original languageEnglish (US)
Pages (from-to)575-591
Number of pages17
JournalExpert Review of Molecular Diagnostics
Volume14
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Barrett Esophagus
Esophageal Neoplasms
Biomarkers
Gastroesophageal Reflux
Goblet Cells
Loss of Heterozygosity
MicroRNAs
Epigenomics
Esophagus
Endoscopy
Epithelium
Biopsy
DNA
Incidence

Keywords

  • Barrett's esophagus
  • Biomarkers
  • DNA content abnormalities
  • Dysplasia
  • Endoscopy
  • Epigenetics
  • Esophageal adenocarcinoma
  • Imaging
  • LOH
  • MiRNA

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression. / Ramzan, Zeeshan; Nassri, Ammar B.; Huerta, Sergio.

In: Expert Review of Molecular Diagnostics, Vol. 14, No. 5, 2014, p. 575-591.

Research output: Contribution to journalArticle

@article{376b1858da3b4f379e4039bbb6a69fc4,
title = "The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression",
abstract = "Long-standing gastroesophageal reflux disease can result in transformation of the normal squamous lining of the esophagus into columnar epithelium (with goblet cells). This condition, Barrett's esophagus (BE), is considered a risk factor for esophageal cancer (EAC) and may be the cause of the increased incidence of EAC over the last few decades. Currently, endoscopy with biopsies revealing dysplasia is the best predictor for neoplastic progression in patients with BE. However, the use of more sophisticated imaging techniques and biomarkers with or without histological assessment may be helpful in more accurate prediction of malignant transformation in these patients. New approaches to the evaluation of BE such as epigenetics, miRNA analysis, detection of DNA content abnormalities and loss of heterozygosity have great potential to shed light on the complex gastroesophageal reflux disease -BE-EAC sequence.",
keywords = "Barrett's esophagus, Biomarkers, DNA content abnormalities, Dysplasia, Endoscopy, Epigenetics, Esophageal adenocarcinoma, Imaging, LOH, MiRNA",
author = "Zeeshan Ramzan and Nassri, {Ammar B.} and Sergio Huerta",
year = "2014",
doi = "10.1586/14737159.2014.919856",
language = "English (US)",
volume = "14",
pages = "575--591",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression

AU - Ramzan, Zeeshan

AU - Nassri, Ammar B.

AU - Huerta, Sergio

PY - 2014

Y1 - 2014

N2 - Long-standing gastroesophageal reflux disease can result in transformation of the normal squamous lining of the esophagus into columnar epithelium (with goblet cells). This condition, Barrett's esophagus (BE), is considered a risk factor for esophageal cancer (EAC) and may be the cause of the increased incidence of EAC over the last few decades. Currently, endoscopy with biopsies revealing dysplasia is the best predictor for neoplastic progression in patients with BE. However, the use of more sophisticated imaging techniques and biomarkers with or without histological assessment may be helpful in more accurate prediction of malignant transformation in these patients. New approaches to the evaluation of BE such as epigenetics, miRNA analysis, detection of DNA content abnormalities and loss of heterozygosity have great potential to shed light on the complex gastroesophageal reflux disease -BE-EAC sequence.

AB - Long-standing gastroesophageal reflux disease can result in transformation of the normal squamous lining of the esophagus into columnar epithelium (with goblet cells). This condition, Barrett's esophagus (BE), is considered a risk factor for esophageal cancer (EAC) and may be the cause of the increased incidence of EAC over the last few decades. Currently, endoscopy with biopsies revealing dysplasia is the best predictor for neoplastic progression in patients with BE. However, the use of more sophisticated imaging techniques and biomarkers with or without histological assessment may be helpful in more accurate prediction of malignant transformation in these patients. New approaches to the evaluation of BE such as epigenetics, miRNA analysis, detection of DNA content abnormalities and loss of heterozygosity have great potential to shed light on the complex gastroesophageal reflux disease -BE-EAC sequence.

KW - Barrett's esophagus

KW - Biomarkers

KW - DNA content abnormalities

KW - Dysplasia

KW - Endoscopy

KW - Epigenetics

KW - Esophageal adenocarcinoma

KW - Imaging

KW - LOH

KW - MiRNA

UR - http://www.scopus.com/inward/record.url?scp=84901251923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901251923&partnerID=8YFLogxK

U2 - 10.1586/14737159.2014.919856

DO - 10.1586/14737159.2014.919856

M3 - Article

C2 - 24831686

AN - SCOPUS:84901251923

VL - 14

SP - 575

EP - 591

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 5

ER -